(Reuters) – The U.S. Food and Drug Administration on Friday approved Regeneron Pharmaceuticals Inc’s cholesterol drug Praluent as a treatment to cut the risk of heart attacks, stroke and other major cardiovascular events. The FDA’s decision will allow the drug, developed along with Sanofi SA, to be prescribed to reduce the overall risk of major… Read More: FDA approves expanded label for Regeneron/Sanofi’s cholesterol drug »
According to WebMD, arteries are blood vessels that carry blood rich and oxygen throughout the body. They go to your brain as well as the tips of your toes. having healthy arteries means preventing the likelihood of heart attacks and strokes. The British Heart Foundation(bhf.org) notes that there are those who have blocked arteries or… Read More: 8 Foods that Clean Arteries and Veins Naturally »
What is Anxiety? [embedded content] [embedded content] “Well, it causes physical symptoms to set off in your body – panic attacks, your heart might begin to beat a little faster, sweaty palms, feeling light headed and dizzy, spaced out, can’t sleep for worrying. Thoughts going round and round in your head, jelly legs and the… Read More: Feeling Anxious? »
Bristol-Myers Squibb investors have been dreading the arrival of Merck’s Keytruda in kidney cancer, one of Opdivo’s key growth areas. Bristol’s execs? Not so much. The company has been preparing for the launch of I-O-plus-TKI regimens—such as the marriage of Keytruda and Pfizer’s Inlyta that won FDA approval Monday, or the Bavencio-Inlyta duo that Pfizer… Read More: Bristol arms itself for kidney-cancer fight as Keytruda threatens Opdivo’s… »